What is Ardelyx's cash & equivalents?

Ardelyx (ARDX) reported cash & equivalents of $31.21M in Q1 2026.

How has Ardelyx's cash & equivalents changed year-over-year?

Ardelyx's cash & equivalents increased by 1.3% year-over-year, from $30.81M to $31.21M.

What is the long-term trend for Ardelyx's cash & equivalents?

Over 5 years (2020 to 2025), Ardelyx's cash & equivalents has grown at a -5.7% compound annual growth rate (CAGR), from $91.03M to $68M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ardelyx ARDX Cash & Equivalents

Cash & Equivalents at other companies

AmgenAMGN

$559M+10.0%

Bausch Health CompaniesBHC

$1.31B+13.4%

AbbVieABBV

$9.39B+81.5%

XER

Xeris Biopharma Holdings, Inc.XERS

$111.75M+91.2%

Neurocrine BiosciencesNBIX

$274.5M+35.8%

Aurinia PharmaceuticalsAUPH

$41.01M-38.3%

Other financials

Income statement

See full

Revenue$94.5M+27.5%

Gross profit$89.7M+45.1%

Operating income-$32.8M+9.8%

Net income-$37.6M+8.6%

EPS (diluted)-$0.15+11.8%

Balance sheet

See full

Total debt$208.3M+34.3%

Total equity$148.6M+2.0%

Total assets$504.5M+23.0%

Cash flow

See full

Operating cash flow-$32.2M+16.2%

CapEx$69.0K-78.8%

Free cash flow-$32.3M+16.7%

Valuation

See full

Market cap$1.53B+25.5%

Enterprise value$1.71B+27.1%

P/S3.6×+0.2×

Profitability

See full

Gross margin92.5%+7.9pp

Operating margin-25.4%—

Net margin-13.6%—

FCF margin-40.9%—

Returns & leverage

See full

Return on equity-39.5%—

Debt / equity1.4×+0.3×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardelyx's cash & equivalents?: Ardelyx (ARDX) reported cash & equivalents of $31.21M in Q1 2026.
How has Ardelyx's cash & equivalents changed year-over-year?: Ardelyx's cash & equivalents increased by 1.3% year-over-year, from $30.81M to $31.21M.
What is the long-term trend for Ardelyx's cash & equivalents?: Over 5 years (2020 to 2025), Ardelyx's cash & equivalents has grown at a -5.7% compound annual growth rate (CAGR), from $91.03M to $68M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.